Current Trends in Carotid Artery Revascularization

Emily B. Crawford; Eric A. Secemsky

doi:10.1055/s-0045-1813702

Seminars in Interventional Radiology, Table of Contents

Semin intervent Radiol
DOI: 10.1055/s-0045-1813702

Review Article

Current Trends in Carotid Artery Revascularization

Authors

Emily B. Crawford

¹Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts

²Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
Eric A. Secemsky

¹Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts

³Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts

Abstract

Carotid artery revascularization plays an important role in stroke prevention among patients with carotid stenosis. While carotid endarterectomy has been the mainstay of revascularization in those with moderate to severe stenosis, the evolution of carotid artery stenting and the recent expansion of Medicare coverage have impacted utilization trends and guideline recommendations. We aim to review currently available data on revascularization techniques, discuss important factors influencing treatment decisions, and explore future directions of carotid stenosis management.

Keywords

carotid artery stenosis - carotid revascularization - carotid endarterectomy - carotid artery stenting

Full Text

References

References
1 Martin SS, Aday AW, Almarzooq ZI. et al. 2024 heart disease and stroke statistics: a report of US and global data from the American Heart Association. Circulation 2024; 149 (08)
2 NVSS - Leading Causes of Death. May 9, 2024. Accessed April 2, 2025 at: https://www.cdc.gov/nchs/nvss/leading-causes-of-death.htm
3 Yaghi S, de Havenon A, Rostanski S. et al. Carotid stenosis and recurrent ischemic stroke: a post-hoc analysis of the POINT trial. Stroke 2021; 52 (07) 2414-2417
4 Cheng SF, Brown MM, Simister RJ, Richards T. Contemporary prevalence of carotid stenosis in patients presenting with ischaemic stroke. Br J Surg 2019; 106 (07) 872-878
5 Pu L, Wang L, Zhang R, Zhao T, Jiang Y, Han L. Projected global trends in ischemic stroke incidence, deaths and disability-adjusted life years from 2020 to 2030. Stroke 2023; 54 (05) 1330-1339
6 Hackam DG. Optimal medical management of asymptomatic carotid stenosis. Stroke 2021; 52 (06) 2191-2198
7 Naylor R, Rantner B, Ancetti S. et al; Esvs Guidelines Committee. Editor's choice - European Society for Vascular Surgery (ESVS) 2023 Clinical Practice Guidelines on the management of atherosclerotic carotid and vertebral artery disease. Eur J Vasc Endovasc Surg 2023; 65 (01) 7-111
8 Wabnitz AM, Turan TN. Symptomatic carotid artery stenosis: surgery, stenting, or medical therapy?. Curr Treat Options Cardiovasc Med 2017; 19 (08) 62
9 Chang RW, Tucker LY, Rothenberg KA. et al. Incidence of ischemic stroke in patients with asymptomatic severe carotid stenosis without surgical intervention. JAMA 2022; 327 (20) 1974-1982
10 Marquardt L, Geraghty OC, Mehta Z, Rothwell PM. Low risk of ipsilateral stroke in patients with asymptomatic carotid stenosis on best medical treatment: a prospective, population-based study. Stroke 2010; 41 (01) e11-e17
11 DeBakey ME. Successful carotid endarterectomy for cerebrovascular insufficiency. Nineteen-year follow-up. JAMA 1975; 233 (10) 1083-1085
12 Rerkasem A, Orrapin S, Howard DP, Rerkasem K. Carotid endarterectomy for symptomatic carotid stenosis. Cochrane Database Syst Rev 2020; 9 (09) CD001081
13 Baiu I, Stern JR. Carotid artery stenting. JAMA 2020; 324 (16) 1690
14 Liang P, Soden P, Wyers MC. et al. The role of transfemoral carotid artery stenting with proximal balloon occlusion embolic protection in the contemporary endovascular management of carotid artery stenosis. J Vasc Surg 2020; 72 (05) 1701-1710
15 Krist AH, Davidson KW, Mangione CM. et al; US Preventive Services Task Force. Screening for asymptomatic carotid artery stenosis: US preventive services task force recommendation statement. JAMA 2021; 325 (05) 476-481
16 de Weerd M, Greving JP, Hedblad B. et al. Prevalence of asymptomatic carotid artery stenosis in the general population: an individual participant data meta-analysis. Stroke 2010; 41 (06) 1294-1297
17 Kleindorfer DO, Towfighi A, Chaturvedi S. et al. 2021 Guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association. Stroke 2021; 52 (07)
18 Barnett HJM, Taylor DW, Haynes RB. et al; North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991; 325 (07) 445-453
19 Warlow C. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. European Carotid Surgery Trialists' Collaborative Group. Lancet 1991; 337 (8752): 1235-1243
20 Barnett HJM, Taylor DW, Eliasziw M. et al; North American Symptomatic Carotid Endarterectomy Trial Collaborators. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. N Engl J Med 1998; 339 (20) 1415-1425
21 Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 1998; 351 (9113): 1379-1387
22 Rothwell PM, Eliasziw M, Gutnikov SA. et al; Carotid Endarterectomy Trialists' Collaboration. Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet 2003; 361 (9352): 107-116
23 Sorber R, Clemens MS, Wang P, Makary MA, Hicks CW. Contemporary trends in physician utilization rates of CEA and CAS for asymptomatic carotid stenosis among medicare beneficiaries. Ann Vasc Surg 2021; 71: 132-144
24 Kim HW, Regenhardt RW, D'Amato SA. et al. Asymptomatic carotid artery stenosis: a summary of current state of evidence for revascularization and emerging high-risk features. J Neurointerv Surg 2023; 15 (07) 717-722
25 Nicolaides AN, Kakkos SK, Kyriacou E. et al; Asymptomatic Carotid Stenosis and Risk of Stroke (ACSRS) Study Group. Asymptomatic internal carotid artery stenosis and cerebrovascular risk stratification. J Vasc Surg 2010; 52 (06) 1486-1496.e1 , 5
26 Kamtchum-Tatuene J, Noubiap JJ, Wilman AH, Saqqur M, Shuaib A, Jickling GC. Prevalence of high-risk plaques and risk of stroke in patients with asymptomatic carotid stenosis: a meta-analysis. JAMA Neurol 2020; 77 (12) 1524-1535
27 Hobson II RW, Weiss DG, Fields WS. et al; The Veterans Affairs Cooperative Study Group. Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. N Engl J Med 1993; 328 (04) 221-227
28 Endarterectomy for asymptomatic carotid artery stenosis. Executive committee for the asymptomatic carotid atherosclerosis study. JAMA 1995; 273 (18) 1421-1428
29 Halliday A, Harrison M, Hayter E. et al; Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group. 10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial. Lancet 2010; 376 (9746): 1074-1084
30 Meschia JF, Edwards L, Roubin G, Brott TG, Lal BK. CREST-2 commitment to rigorous assessment of carotid stenting for primary prevention of stroke. Stroke Vasc Intervent Neurol 2024; 4 (03) e001227
31 Brott TG, Hobson II RW, Howard G. et al; CREST Investigators. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med 2010; 363 (01) 11-23
32 Yadav JS, Wholey MH, Kuntz RE. et al; Stenting and Angioplasty with Protection in Patients at High Risk for Endarterectomy Investigators. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 2004; 351 (15) 1493-1501
33 Gurm HS, Yadav JS, Fayad P. et al; SAPPHIRE Investigators. Long-term results of carotid stenting versus endarterectomy in high-risk patients. N Engl J Med 2008; 358 (15) 1572-1579
34 Wang J, Bai X, Wang T, Dmytriw AA, Patel AB, Jiao L. Carotid stenting versus endarterectomy for asymptomatic carotid artery stenosis: a systematic review and meta-analysis. Stroke 2022; 53 (10) 3047-3054
35 Rosenfield K, Matsumura JS, Chaturvedi S. et al; ACT I Investigators. Randomized trial of stent versus surgery for asymptomatic carotid stenosis. N Engl J Med 2016; 374 (11) 1011-1020
36 Halliday A, Bulbulia R, Bonati LH. et al; ACST-2 Collaborative Group. Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy. Lancet 2021; 398 (10305): 1065-1073
37 Reiff T, Eckstein HH, Mansmann U. et al; SPACE-2 Investigators. Carotid endarterectomy or stenting or best medical treatment alone for moderate-to-severe asymptomatic carotid artery stenosis: 5-year results of a multicentre, randomised controlled trial. Lancet Neurol 2022; 21 (10) 877-888
38 Stonko DP, Goldsborough III E, Kibrik P, Zhang G, Holscher CM, Hicks CW. Use of transcarotid artery revascularization, transfemoral carotid artery stenting, and carotid endarterectomy in the US from 2015 to 2019. JAMA Netw Open 2022; 5 (09) e2231944
39 Percutaneous Transluminal Angioplasty (PTA) of the Carotid Artery Concurrent with Stenting. Centers for Medicare & Medicaid Services. Accessed November 12, 2025 at: https://www.cms.gov/medicare-coverage-database/view/ncacal-decision-memo.aspx?proposed=N&ncaid=311&ncacaldoctype=all&status=all&sortBy=status&bc=17
40 Kwolek CJ, Jaff MR, Leal JI. et al. Results of the ROADSTER multicenter trial of transcarotid stenting with dynamic flow reversal. J Vasc Surg 2015; 62 (05) 1227-1234
41 Naazie IN, Cui CL, Osaghae I, Murad MH, Schermerhorn M, Malas MB. A systematic review and meta-analysis of transcarotid artery revascularization with dynamic flow reversal versus transfemoral carotid artery stenting and carotid endarterectomy. Ann Vasc Surg 2020; 69: 426-436
42 Malas MB, Leal J, Kashyap V, Cambria RP, Kwolek CJ, Criado E. Technical aspects of transcarotid artery revascularization using the ENROUTE transcarotid neuroprotection and stent system. J Vasc Surg 2017; 65 (03) 916-920
43 Kashyap VS, Schneider PA, Foteh M. et al; ROADSTER 2 Investigators*. Early outcomes in the ROADSTER 2 study of transcarotid artery revascularization in patients with significant carotid artery disease. Stroke 2020; 51 (09) 2620-2629
44 Kashyap VS, So KL, Schneider PA. et al. One-year outcomes after transcarotid artery revascularization (TCAR) in the ROADSTER 2 trial. J Vasc Surg 2022; 76 (02) 466-473.e1
45 Plessers M, Van Herzeele I, Hemelsoet D. et al. Transcervical carotid stenting with dynamic flow reversal demonstrates embolization rates comparable to carotid endarterectomy. J Endovasc Ther 2016; 23 (02) 249-254
46 Malas MB, Dakour-Aridi H, Wang GJ. et al. Transcarotid artery revascularization versus transfemoral carotid artery stenting in the Society for Vascular Surgery Vascular Quality Initiative. J Vasc Surg 2019; 69 (01) 92-103.e2
47 Cui CL, Dakour-Aridi H, Lu JJ, Yei KS, Schermerhorn ML, Malas MB. In-hospital outcomes of urgent, early, or late revascularization for symptomatic carotid artery stenosis. Stroke 2022; 53 (01) 100-107
48 Dakour-Aridi H, Kashyap VS, Wang GJ, Eldrup-Jorgensen J, Schermerhorn ML, Malas MB. The impact of age on in-hospital outcomes after transcarotid artery revascularization, transfemoral carotid artery stenting, and carotid endarterectomy. J Vasc Surg 2020; 72 (03) 931-942.e2
49 Schermerhorn ML, Liang P, Eldrup-Jorgensen J. et al. Association of transcarotid artery revascularization vs transfemoral carotid artery stenting with stroke or death among patients with carotid artery stenosis. JAMA 2019; 322 (23) 2313-2322
50 Straus S, Yadavalli SD, Allievi S. et al. Seven years of the transcarotid artery revascularization surveillance project, comparison to transfemoral stenting and endarterectomy. J Vasc Surg 2024; 80 (05) 1455-1463
51 Rothenberg P, Pillai L, Beidelman E, Kalbaugh C, Zimmerman P, Minc S. Transradial carotid artery stenting is protective for postoperative transient ischemic attack and stroke. J Vasc Surg 2024; 80 (03) e17-e18
52 Ruzsa Z, Nemes B, Pintér L. et al. A randomised comparison of transradial and transfemoral approach for carotid artery stenting: RADCAR (radial access for carotid artery stenting) study. EuroIntervention 2014; 10 (03) 381-391
53 Rodriguez-Calienes A, Chavez-Ecos FA, Espinosa-Martinez D. et al. Transradial access versus transfemoral approach for carotid artery stenting: a systematic review and meta-analysis. Stroke Vasc Intervent Neurol 2024; 4 (02) e001156
54 AbuRahma AF, Avgerinos ED, Chang RW. et al. Society for vascular surgery clinical practice guidelines for management of extracranial cerebrovascular disease. J Vasc Surg 2022; 75 (1S): 4S-22S
55 Rothwell PM, Eliasziw M, Gutnikov SA, Warlow CP, Barnett HJ. Carotid Endarterectomy Trialists Collaboration. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 2004; 363 (9413): 915-924
56 Fairhead JF, Mehta Z, Rothwell PM. Population-based study of delays in carotid imaging and surgery and the risk of recurrent stroke. Neurology 2005; 65 (03) 371-375
57 Squizzato F, Zivelonghi C, Menegolo M. et al. A systematic review and meta-analysis on the outcomes of carotid endarterectomy after intravenous thrombolysis for acute ischemic stroke. J Vasc Surg 2025; 81 (01) 261-267.e2
58 Thomas SE, Plumber N, Venkatapathappa P, Gorantla V. A Review of Risk Factors and Predictors for Hemorrhagic Transformation in Patients with Acute Ischemic Stroke. Bozzani A, ed. Int J Vasc Med 2021; 2021: 1-12
59 Kakkos SK, Nicolaides AN, Charalambous I. et al; Asymptomatic Carotid Stenosis and Risk of Stroke (ACSRS) Study Group. Predictors and clinical significance of progression or regression of asymptomatic carotid stenosis. J Vasc Surg 2014; 59 (04) 956-967.e1
60 Venkatachalam S. Asymptomatic carotid stenosis: immediate revascularization or watchful waiting?. Curr Cardiol Rep 2014; 16 (01) 440
61 Brott TG, Roubin GS, Moore WS, Meschia JF. Carotid artery disease: then and now. Stroke Vasc Intervent Neurol 2024; 4 (02) e001076
62 Gray WA, Metzger DC, Zidar J. et al. The performance II trial. JACC Cardiovasc Interv 2025; 18 (03) 367-376
63 Pini R, Faggioli G, Paraskevas KI. et al. Carotid artery stenting with double-layer stent: a systematic review and meta-analysis. J Endovasc Ther 2024; 31 (03) 339-349
64 Cheng SF, van Velzen TJ, Gregson J. et al. The 2nd European Carotid Surgery Trial (ECST-2): rationale and protocol for a randomised clinical trial comparing immediate revascularisation versus optimised medical therapy alone in patients with symptomatic and asymptomatic carotid stenosis at low to intermediate risk of stroke. Trials 2022; 23 (01) 606
65 ECST-2: No Benefit of Carotid Revascularization on Top of Best Medical Therapy. TCTMD.com. May 26, 2023. Accessed March 27, 2025 at: https://www.tctmd.com/news/ecst-2-no-benefit-carotid-revascularization-top-best-medical-therapy
66 Gasior SA, O'Donnell JPM, Davey M. et al. Optimal management of asymptomatic carotid artery stenosis: a systematic review and network meta-analysis. Eur J Vasc Endovasc Surg 2023; 65 (05) 690-699
67 Bonati LH, Kakkos S, Berkefeld J. et al. European Stroke Organisation guideline on endarterectomy and stenting for carotid artery stenosis. Eur Stroke J 2021; 6 (02) I-XLVII